Metastatic Squamous Cell Carcinoma of the Hypopharynx

Explore clinical trials studying Metastatic Squamous Cell Carcinoma of the Hypopharynx. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Squamous Cell Carcinoma of the Hypopharynx trial results

Completed

Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck

NCT01064479

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +29 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

MD Anderson Regional Care Center-Katy Houston, Texas, United States

MD Anderson Regional Care Center-Bay Area Nassau Bay, Texas, United States

MD Anderson Regional Care Center-Sugar Land Sugar Land, Texas, United States

View Trial Details

Active, Not Recruiting

Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer

NCT00494182

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +15 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Metastatic Squamous Cell Carcinoma of the Hypopharynx

Metastatic Squamous Cell Carcinoma of the Hypopharynx trial results

Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck

Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer

Related conditions